Abstract
Peroxisome proliferator-activated receptor-γ (PPAR-γ) ligands constitute important insulin sensitizers that have already been used for the treatment of human metabolic disorders, exerting also pleiotropic effects on inflammatory related diseases and cancer. Ischemia-reperfusion injury that is mainly associated with organ transplantation constitutes a serious complication with a great relevance in clinical practice. Accumulating experimental data have recently revealed that natural and synthetic PPAR-γ ligands exert beneficial effects against ischemia-reperfusion injury. The present review summarizes the available information on the role of PPAR-γ ligands in ischemia-reperfusion injury amongst the different organ systems. Taking into consideration the data so far, PPAR-γ ligands seem to represent potential therapeutic agents in the aim to reduce or even prevent injury associated with ischemia-reperfusion.
Keywords: Ischemia Reperfusion Injury, Peroxisome proliferator-activated receptor-γ (PPAR-γ), insulin sensitizers, human metabolic disorders, inflammatory, growth hormone protein-1 (GHP-1)
Current Molecular Medicine
Title: Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Ligands: Novel Pharmacological Agents in the Treatment of Ischemia Reperfusion Injury
Volume: 8 Issue: 6
Author(s): Costas Giaginis, Gerasimos Tsourouflis and Stamatios Theocharis
Affiliation:
Keywords: Ischemia Reperfusion Injury, Peroxisome proliferator-activated receptor-γ (PPAR-γ), insulin sensitizers, human metabolic disorders, inflammatory, growth hormone protein-1 (GHP-1)
Abstract: Peroxisome proliferator-activated receptor-γ (PPAR-γ) ligands constitute important insulin sensitizers that have already been used for the treatment of human metabolic disorders, exerting also pleiotropic effects on inflammatory related diseases and cancer. Ischemia-reperfusion injury that is mainly associated with organ transplantation constitutes a serious complication with a great relevance in clinical practice. Accumulating experimental data have recently revealed that natural and synthetic PPAR-γ ligands exert beneficial effects against ischemia-reperfusion injury. The present review summarizes the available information on the role of PPAR-γ ligands in ischemia-reperfusion injury amongst the different organ systems. Taking into consideration the data so far, PPAR-γ ligands seem to represent potential therapeutic agents in the aim to reduce or even prevent injury associated with ischemia-reperfusion.
Export Options
About this article
Cite this article as:
Giaginis Costas, Tsourouflis Gerasimos and Theocharis Stamatios, Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Ligands: Novel Pharmacological Agents in the Treatment of Ischemia Reperfusion Injury, Current Molecular Medicine 2008; 8 (6) . https://dx.doi.org/10.2174/156652408785748022
DOI https://dx.doi.org/10.2174/156652408785748022 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mechanisms of Apoptosis in Retinitis Pigmentosa
Current Molecular Medicine mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems
Current Drug Targets An Insight Into Mitochondrial Dysfunction and its Implications in Neurological Diseases
Current Drug Targets Patent Selections
Recent Patents on Anti-Infective Drug Discovery Anesthetic Cardioprotection: The Role of Adenosine
Current Pharmaceutical Design Regulation of Inflammatory Responses by Sensory Neurons: Molecular Mechanism(s) and Possible Therapeutic Applications
Current Medicinal Chemistry Tailoring NO Donors Metallopharmaceuticals: Ruthenium Nitrosyl Ammines and Aliphatic Tetraazamacrocycles
Current Medicinal Chemistry Bioactive Polyphenols from Grapes and Wine Emphasized with Resveratrol
Current Pharmaceutical Design Chemistry and Pharmacology of Bioactive Molecule -Coenzyme Q10: A Brief Note
Current Bioactive Compounds Antioxidative Peptides: Trends and Perspectives for Future Research
Current Medicinal Chemistry From Erythropoietin to Its Peptide Derivatives: Smaller but Stronger
Current Protein & Peptide Science The Role of Venous Abnormalities in Neurological Disease
Reviews on Recent Clinical Trials Baccharis trimera Improves the Antioxidant Defense System and Inhibits iNOS and NADPH Oxidase Expression in a Rat Model of Inflammation
Current Pharmaceutical Biotechnology Conjugates of Natural Compounds with Nitroxyl Radicals as a Basis for Creation of Pharmacological Agents of New Generation
Current Medicinal Chemistry Effect of Micronized Purified Flavonoid Fraction Therapy on Endothelin-1 and TNF-α Levels in Relation to Antioxidant Enzyme Balance in the Peripheral Blood of Women with Varicose Veins
Current Vascular Pharmacology Sonic Hedgehog Signaling Activation Promotes Cardioprotective Strategies
Current Signal Transduction Therapy Clinical Applications of Cardiovascular Magnetic Resonance
Current Pharmaceutical Design Oxidative Stress and Post-Stroke Depression: Possible Therapeutic Role of Polyphenols?
Current Medicinal Chemistry The Role of ER Stress-Induced Apoptosis in Neurodegeneration
Current Alzheimer Research Herbal Medicines for Diabetes Management and its Secondary Complications
Current Diabetes Reviews